315
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Updated results of a phase 2 study of panobinostat combined with melphalan, thalidomide and prednisone (MPT) in relapsed/refractory multiple myeloma

, , , , &
Pages 1271-1273 | Received 08 Jun 2017, Accepted 20 Aug 2017, Published online: 11 Sep 2017
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (6.7 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.